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The effects of psychotherapy for depression on
anxiety symptoms: a meta-analysis
Erica Weitz, Annet Kleiboer, Annemieke van Straten and Pim Cuijpers
Department of Clinical, Neuro and Developmental Psychology, EMGO Institute for Health and Care Research, Vrije
Universiteit Amsterdam, Van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands
Background. More than half of patients who present with depressive disorders also have ele-
vated comorbid anxiety symptoms. Given the high comorbidity between these disorders, it is
important to understand the extent that psychotherapies for depression additionally amelior-
ate symptoms of anxiety.
Methods. Systematic searches were conducted in PubMed, PSYCinfo, EMBASE, and the
Cochrane Registry of Controlled Trials. Included studies were randomized controlled trials
that compared psychotherapy compared with a control condition for the treatment of adults
with a primary diagnosis or elevated symptoms of depression and that examined the effects of
treatment on anxiety outcomes. Acute phase depression and anxiety (continuous measure)
outcomes were extracted. Effect sizes were calculated by subtracting the average post-treatment
scores of the psychotherapy group from the average post-treatment scores of the comparison
group divided by the pooled standard deviation.
Results. Fifty-two studies of varying quality met the inclusion criteria. Pooled effect sizes
showed that anxiety outcomes were significantly lower in the psychotherapy conditions
than in control conditions at post-treatment [g = 0.52; 95% confidence interval (CI) 0.44–
0.60; NNT (numbers-needed-to-treat) = 3.50]. Moderate heterogeneity was observed (I2 =
55%, 95% CI 40–66). Bivariate metaregression analysis revealed a significant association
between depression and anxiety effect sizes at post-treatment Longer-term follow-ups of up
to 14 months post-baseline showed indications for a small lasting effect of psychotherapy
on anxiety outcomes (g = 0.27).
Conclusions. This meta-analysis provides evidence that psychotherapy aimed at depression
can also reduce anxiety symptoms in relation to control conditions.
Introduction
It is well established that depressive and anxiety symptoms often co-occur in patients with a
primary diagnosis of either a depressive or anxiety disorder (Brown et al. 2001; Wiethoff et al.
2010). This particular co-morbid symptomatology can complicate treatment and lead to wor-
sening outcomes (Joffe et al. 1993; Zajecka & Ross 1995; Fava et al. 2004; Wiethoff et al. 2010).
Given the high overlap of depressive and anxiety symptoms, it is important to understand the
extent to which psychotherapies designed for the treatment of depression can additionally
ameliorate symptoms of anxiety.
Although depression and anxiety disorders are classified separately in the DSM, high rates
of co-occurring symptoms of anxiety and depression, genetic links, and similarities in the eti-
ology and course of the disorders have led some to consider anxiety and depression as part of a
coherent spectrum (Goldberg et al. 2009). Despite the evidence of co-occurrence, few studies
have examined the efficacy of psychological treatments designed for targeting comorbid anx-
iety and depressive disorders simultaneously (Smits et al. 2009). This may be due to treatment
efficacy literature being mainly structured by a psychiatric disorder. Thus, effective psycho-
logical and pharmacologic therapies have been developed for the treatment of depression or
anxiety disorders separately and the effects of these treatments cannot be extended to symp-
toms of comorbid disorders.
Previous meta-analyses have shown that varied psychotherapies such as cognitive behav-
ioral therapy (CBT), interpersonal psychotherapy (IPT), problem-solving therapy (PST),
and possibly psychodynamic psychotherapy, as well as pharmacotherapies such as SSRIs
and MAOIs are effective for treating depression (De Maat et al. 2006; Malouff et al. 2007;
Cuijpers et al. 2011, 2013b). Meanwhile, among anxiety disorders, CBT administered alone
or in combination with pharmacotherapy have been the most widely-studied and proven effi-
cacious treatments for anxiety symptoms (Furukawa et al. 2004; Hunot et al. 2007; Acarturk
et al. 2009; Sanchez-Meca et al. 2010; Cuijpers et al. 2014).
The high prevalence of co-morbid depression and anxiety spurred several meta-analyses
examining whether CBT for the treatment of anxiety disorders reduces comorbid depressive
symptoms. These meta-analyses demonstrate that CBT for Generalized Anxiety Disorder
(GAD), Social Anxiety Disorder, and Panic Disorder significantly reduces depressive
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symptoms compared with control conditions, with effect sizes
ranging from 0.60 to 1.00 (Mitte, 2005; Hunot et al. 2007;
Hofmann & Smits, 2008; Acarturk et al. 2009; Sanchez-Meca
et al. 2010; Cuijpers et al. 2014). In addition, a recent
meta-analysis comparing the effects of treatments designed for
anxiety disorders with depression treatments directly, found no
differences between the two treatments on depression outcomes
(Cuijpers et al. 2016).
Although this provides robust meta-analytic evidence that
treatments designed for and studied in populations with anxiety
disorders also significantly reduce depressive symptoms, data on
whether typical psychotherapies for depression also reduce symp-
toms of anxiety have not yet been aggregated. Individual rando-
mized controlled trials (RCTs) have shown mixed results with
equal numbers of studies indicating a significant reduction in
anxiety symptoms between depression psychotherapy and control
conditions (e.g., Serfaty et al. 2009; Bohlmeijer et al. 2011;
Buntrock et al. 2015; Milgrom et al. 2015) as demonstrating no
significant difference between depression psychotherapies and
control conditions (e.g. Chesney et al. 2003; Lynch et al. 2004;
Chiesa et al. 2012; Lemma & Fonagy, 2013; Buhrman, et al.
2015), and a few studies even finding negative effects (see
Fig. 2). Since individual RCTs have limited statistical power,
aggregating these data would provide more robust evidence for
whether depression psychotherapies ameliorate anxiety symp-
toms. This information could be valuable to clinicians to better
support their treatment selections. Thus, this meta-analysis aims
to examine whether the effects of psychotherapies for depression
compared with control conditions reduces post-treatment anxiety
symptoms, in addition to post-treatment depressive symptoms. It
also examines the relationship between depression and anxiety
symptoms after psychotherapeutic treatment.
Methods
Identification and study selection
A database of RCTs on psychological treatment of adult depres-
sion was utilized for study identification and selection. This data-
base has been described elsewhere (Cuijpers et al. 2008) and has
been used in a series of previously published meta-analyses
(http://www.evidencebasedpsychotherapies.org). It was developed
through comprehensive literature searches (from 1966 to January,
1 2016). During these searches, 16 365 abstracts were examined
for inclusion from PubMed, PSYCinfo, EMBASE, and the
Cochrane Registry of Controlled Trials, and previously conducted
meta-analyses. Studies on the treatment of adult depression were
examined for inclusion. From the 16 407 abstracts identified and
examined against inclusion and exclusion criteria (13 384 after
duplicate removal), 1885 full-text articles were retrieved for
potential inclusion in the database. A total of 645 studies met cri-
teria, were incorporated in the database, and were then checked
for inclusion in this meta-analysis.
This study includes RCTs comparing psychotherapeutic treat-
ment aimed at treating depression compared with control condi-
tions (wait-list, pill placebo, care-as-usual, other) for adults with a
primary diagnosis or elevated symptoms of depression established
by a standardized diagnostic interview or a standardized clinician
or self-report measure of depressive symptoms, which utilize a
continuous measure of anxiety (general symptoms). No language
restrictions were applied. Psychotherapeutic treatment was
defined according to previously delineated criteria (Cuijpers
et al. 2008) and included interventions in which either verbal
communication between a therapist and client was central to
the psychotherapy, or psychological treatment in book or internet
format which clients work through individually supported by a
therapist (by telephone or e-mail). Usual care was defined as
patients receiving the same care they would have received if
they never entered the trial.
Studies of patients under 18 years, those with an intellectual
disability, or that included less than three treatment sessions
were excluded. RCTs not reporting outcome scores on a continu-
ous, validated measure of anxiety symptoms were excluded as
effect sizes that pertain to this studies’ main question could not
be calculated. Studies of patients with co-morbid medical diagno-
ses or post-partum depression (special populations) were not
excluded.
Quality assessment and data extraction
Quality of the included studies was assessed using four criteria of
the Cochrane collaboration’s ‘risk of bias’ tool (eds Higgins &
Green, 2011) which assesses study validity by examining possible
sources of bias within the RCTs. This included assessing whether
(1) randomization was adequately generated, (2) and properly
concealed, (3) if appropriate measures were taken to prevent
knowledge of the treatment allocation to parties, and (4) if appro-
priate methods for handling missing data were utilized. A negative
score was given to a study when quality criteria were not handled
adequately or there was not enough information to rate the item.
Data extracted from the published papers included continuous
outcomes on depression or anxiety symptom scales and reported
characteristics of the studies such as recruitment method (com-
munity or clinical populations) target group of the study (adults
or other populations like comorbid medical diagnosis or older
adults), and depression inclusion criteria. We also reported sev-
eral facets of the psychological treatment: treatment delivery
(group, individual, guided self-help), treatment length and type
of psychotherapy (CBT or other). ‘Other’ psychotherapy includes
IPT, PST, psychodynamic psychotherapy, and others. These were
combined since too few studies are available within each treat-
ment to analyze them separately. Two independent raters per-
formed the data extraction (EW, AK).
Meta-analysis
Effect sizes indicating the difference between psychotherapy and
controls on post-treatment anxiety or depression outcome meas-
ure scores were calculated (Hedges’ g) by subtracting the average
post-treatment anxiety score of the psychotherapy group from the
average post-treatment anxiety score of the comparison group and
dividing by the pooled standard deviation. The same calculation
was conducted for post-treatment depression scores. If post-
treatment effect sizes were not reported, mean depression or anx-
iety symptom change from pre-treatment to post-treatment was
utilized. Effect sizes of 0.8 are considered large, 0.5 moderate,
and 0.2 and below are considered to be small (Cohen, 1988).
Whenever possible, effect sizes associated with the
intention-to-treat samples were utilized, however when not avail-
able, completer samples effect sizes were used. If two depression
or anxiety measures were utilized, an average effect size was com-
puted. In the event that two control groups were utilized in a sin-
gle RCT, care-as-usual was chosen as the control as it mimics
real-world practice. If CAU was not available, then another
Psychological Medicine 2141
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control condition was chosen as the comparison. In order to min-
imize overestimation of the effect sizes, wait-list controls were not
chosen as the comparison condition when another control was
available because they produce significantly larger effect sizes
(Furukawa et al. 2014).
The Comprehensive Meta-analysis program (CMA version 3)
was utilized to calculate pooled mean effect sizes. Random effects
models were chosen for all analyses as we expected some hetero-
geneity between studies. In addition to standardized effect sizes,
we also calculated the numbers-needed-to-treat (NNT) using
the Kraemer & Kupfer (2006) formula. The NNT designates the
number of patients that would need to be treated with psycho-
therapy to have one additional positive outcome compared to a
control condition.
Heterogeneity between included studies was examined by cal-
culating I2, which quantifies heterogeneity uncovered by the
Q-statistic and reports (in percentages) how much overall vari-
ance is attributed to between-study variance. An I2 of 25% indi-
cates low heterogeneity, 50% moderate heterogeneity, and 75%
indicated high heterogeneity. The 95% confidence interval (CI)
around I2 is also calculated using the non-central chi-square
approach in the heterogi module of STATA (Ioannidis et al.
2007; von Hippel, 2015).
Subgroup analyses were conducted to determine how varying
sample and study characteristics influence the difference between
psychotherapy and control conditions in treating anxiety symp-
toms. Subgroup analysis was conducted using the mixed effect
model, which pools subgroups of studies using the random effects
model, and tests for subgroup differences by using the fixed
effects model. Subgroups were pooled according to the type of
psychotherapy utilized, method of recruitment, format of the psy-
chotherapy, study eligibility criteria (including depressive symp-
toms v. diagnosis of depression), type of control condition,
study quality, and inclusion of special populations.
In order to understand the relationship between depression
and anxiety outcomes, additional metaregression analyses were
conducted in CMA. Bivariate analysis examined the relationship
between depression effect sizes and anxiety effect sizes (with
anxiety ES as the dependent variable). Multivariate metaregres-
sion analysis examined this relationship while controlling for
relevant study and clinical characteristics. Because studies
included varying lengths of treatments, metaregression analysis
examined number of treatment sessions as a moderator of treat-
ment outcomes.
Publication bias was assessed in several ways. First, a funnel
plot of effect sizes was visually inspected to see whether a larger
number of trials clustered in the bottom right, which would
indicate publication bias. Duval and Tweedie’s trim-and-fill
procedure was utilized in order to calculate the approximate
number of studies missing from the funnel plot and transform
this into an effect size corrected for publication bias. Egger’s test
of the intercept, which quantifies bias detected in the funnel
plot, was performed using procedures outlined by Hedges &
Olkin (1985).
Results
From the 645 studies included in the database, a total of 52 studies
met the inclusion criteria for this meta-analysis. Three hundred
eighty-three studies were excluded for not having control condi-
tions, 186 studies did not have anxiety measurements, and 24
were excluded for other reasons (e.g. could not extract data).
The PRISMA flowchart outlining the inclusion process is pre-
sented in Fig. 1. Specific design and clinical characteristics of
the studies are presented in Table 1.
Characteristics of included studies
A total of 52 RCT trials with 62 comparisons between psycho-
therapy (3072 patients) v. control conditions (2665 patients)
and reporting post-treatment anxiety symptom inventories were
included in this meta-analysis. Out of the 52 included trials, 22
were aimed at adults in general, nine trials focused on older
adults, 13 trials included adults with medical diseases, and eight
trials were aimed at another specific group such as post-partum
depression. A total of 30 studies recruited participants from com-
munity sources, 12 trials recruited strictly from clinical popula-
tions, and 10 trials recruited in another manner or used a
combination of methods.
Various psychotherapies for depression were examined in the
included trials. Of the 62 comparisons about half (n = 33) utilized
CBT as the psychotherapy and 29 examined other types of psy-
chotherapy (Table 1). The control condition comparison groups
also varied: care-as-usual was examined in 29 comparisons, wait-
list in 23 comparisons, and another type of control such as
attention-controls or psychoeducation in 10 comparisons. In
terms of psychotherapy format, 26 comparisons delivered treat-
ment via individual psychotherapy, 17 comparisons used group
therapy (one additional trial used both individual and group
treatment), and 17 comparisons utilized guided self-help. The
number of treatment sessions ranged from three to 20 in the
active interventions (mode: 8). Most studies were conducted in
Europe or North America, and seven were conducted in other
countries.
Measurements included in the trials included commonly
used self-report measures of anxiety symptoms. Fourteen studies
(15 comparisons) administered the anxiety subscale of the
Hospital Anxiety and Depression Scale (HADS), 16 studies (19
comparisons) administered the Beck Anxiety Inventory (BAI)
alone or in combination with another anxiety scale, 20 studies
used other valid anxiety scales. Most of the included measures tar-
get general symptoms of anxiety and do not pertain to specific
anxiety disorders, allowing for thorough comparison. Two studies
used the Penn State Worry Scale (PSWS), which is often used in
studies of GAD, but assesses more general symptoms of anxiety.
Two other studies utilized scales specifically for the measurement
of PTSD symptoms (Meyer et al. 1990). For this reason, a sensi-
tivity analysis was conducted excluding these studies.
Measurements of depression included common self-report and
clinician-rated measurements with a majority of trials utilizing the
CES-D, HAM-D, or BDI alone or in combination with another
depression measure. Ten studies used other validated depression
measures.
Quality assessment
Study qualityof the included trials varied: 34 out of 52 studies used an
adequate generation of the randomization sequence, 33 studies
reported allocating participants to conditions by an independent
party, 50 studies reported using self-report outcomes and two blind
assessors, and 37 studies utilized intention-to-treat samples indicat-
ing that missing data were handled appropriately. Thirty-five studies
scored positive on three or four items of the risk of bias, and the
remaining 17 studies scored positive on 0–2 items.
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Anxiety outcomes
Differences between psychotherapy and control conditions on
post-treatment anxiety symptoms were examined in 62 compari-
sons and the pooled effect size showed significantly lower anxiety
symptoms in psychotherapy conditions than in control conditions
at post-treatment (g = 0.52; 95% CI 0.44–0.60; NNT = 3.50)
(Table 2, Fig. 2). Moderate heterogeneity was observed (I2 =
55%, 95% CI 40–66). Outliers (nine comparisons), with CIs posi-
tioned outside of the pooled effect CIs were omitted from the ana-
lysis and an effect size of g = 0.49 (95% CI 0.42–0.55; I2 = 14, 95%
CI 0–40) was observed (Table 2). Multiple comparisons from a
single study were included in 10 trials, thereby violating the inde-
pendence assumption. Because this may artificially reduce hetero-
geneity, two additional sensitivity analyses including only one
effect per study (the highest, then the lowest) were conducted.
In both sensitivity analyses, effect sizes and heterogeneity differed
little from the original analysis (Table 2). A further sensitivity
analysis excluding studies utilizing PTSD measures found similar
effect sizes (g = 0.52; 95% CI 0.44–0.60).
Additional analyses were conducted to examine effect sizes by
specific anxiety measures. Examining only studies using the BAI
revealed an effect size of g = 0.40 (95% CI 0.27–0.53). Studies
that utilized the HADS-A produced an effect size of g = 0.58
(95% CI 0.43–0.73).
The funnel plot andDuval and Tweedie’s trim and fill procedure
showed evidence for little publication bias. In addition, Egger’s test
of the intercept was not significant ( p = 0.32). When adjusting for
missing studies/small sample bias the effect size estimate was simi-
lar to the observed effect size (g = 0.50; 95% CI 0.42–0.59).
Depression outcomes
Secondary analysis examined the overall effect size of psychother-
apy compared with control conditions on outcome depression
Fig. 1. Flowchart of study inclusion.
Psychological Medicine 2143
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Table 1. Selected characteristics of studies examining the effects of psychotherapy for depression on anxiety
Study Target population Depression Psycho-therapy Control Format Nses N post PST N post CTRL Anxiety outcome Qual
a Coun-try
1. Ammerman et al. (2013) Mothers Dep symptoms CBT CAU Indiv 15 47 46 BSL-A − + sr + US
2. Andersson et al. (2002) Adults MDD CBT Other Gsh 5 36 49 BAI + + sr − SE
3. Batink et al. (2013) Adults Dep symptoms MBCT TAU Grp 8 64 66 PSWQ + + sr + NL
4. Bohlmeijer et al. (2011) Adults Dep symptoms ACT WL Grp 8 49 44 HADS-A + + sr + NL
5. Buhrman et al. (2015) Adults w/chronic pain Dep symptoms CBT WL Gsh 8 28 24 BAI + + sr + SE
6. Buntrock et al. (2015) Adults Dep symptoms CBT Other Gsh 6 202 204 HADS-A + + sr + DE
7. Carlbring et al. (2013) Adults Dep symptoms BA + ACT WL Gsh 8 40 40 BAI + + sr + SE
8. Chesney et al. (2003) Adults with HIV Dep symptoms Other Other Grp 10 46 44 STAI − − sr − US
9. Chiesa et al. (2012) Adults MDD MBCT Other Indiv 8 23 20 BAI + + sr − IT
10. Cramer et al. (2011) Adults Dep symptoms CBT CAU Grp 12 46 19 BAI + + sr − US
11. Dobkin et al. (2011) Adults w/parkinsons Mood disorder CBT Other Indiv 10 41 39 HADS-A + + sr + US
12. Evans & Connis (1995) Adults w/Cancer Dep symptoms CBT CAU Grp 8 27 24 SCL-A − − sr − US
SUP* 21
13. Faramarzi et al. (2008) Women w/infertility MDD CBT CAU Grp 10 29 30 ASQ − − sr − IR
14. Fledderus et al. (2012) Adults Dep symptoms ACT-E WL Gsh 9 125 126 HADS-A +− sr + NL
ACT-M 125
15. Freedland et al. (2010) Adults w/coronary bypass Mood disorder CBT CAU Indiv 9 41 40 BAI + + sr + US
SUP 42
16. Freedland et al. (2015) Adults w/heart failure MDD CBT e-CAU Indiv 24 79 79 BAI + + sr + US
17. Gitlin et al. (2014) Older African American adults Dep symptoms Other WL Indiv 10 106 102 STAI (state) + + sr + US
18. Grote et al. (2009) Pre/Post-partum Dep symptoms IPT e-CAU Indiv 8 25 28 BAI − − sr + US
19. Haringsma et al. (2006) Older adults Dep symptoms CBT WL Grp 10 52 58 HADS-A − − sr + NL
20. Hautzinger & Welz (2004) Older adults Dep symptoms CBT WL Grp 12 55 30 SCL-A + + sr + DE
21. Hsiao et al. (2014) Adjustment disorder w/dep mood Dep symptoms Other (BMS) CAU Grp 8 33 37 STAI + + sr + TW
22. Johansson et al. (2012a) Adults MDD DYN Other Gsh 9 46 46 BAI/GAD-7 + + sr + SE
23. Johansson et al. (2012b) Adults MDD CBT std Other Gsh 8 34 42 BAI + + sr + SE
CBT tail 36
24. Jonkers et al. (2012) Older adults w/chronic illness Dep symptoms Other (Life Review) CAU Gsh 10 183 178 SCL-A + + sr + NL
25. Kelly et al. (1993) Older adults Dep symptoms CBT CAU Grp 8 27 27 SCL-A − − sr − US
SUP 14
26. Kivi et al. (2014) Adults Dep symptoms CBT CAU Indiv 7 45 47 BAI − − sr − SE
27. Korte et al. (2012) Older adults Dep symptoms Other (Life Review) CAU Grp 8 100 102 HADS-A + + sr + NL
28. Laidlaw et al. (2008) Older adults MDD CBT CAU Indiv 8 20 20 PSWI + + sr − UK
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30. Lemma & Fonagy (2013) Adults Dep symptoms DYN Other Grp 8 8 8 GAD-7 −− sr + UK
31. Lynch et al. (2004) Adults Dep symptoms PST CAU Gsh 6 9 13 DHP-A −− sr − US
32. Maina et al. (2005) Adults Mood disorder PST WL Indiv 20 10 10 HAM-A −− + + IT
SUP 10
33. Martin et al. (2015) Adults w/migraine MDD CBT CAU Indiv 12 18 26 BAI −− sr − AU
34. Milgrom et al. (2015) Women w/antenatal depression MDD CBT CAU Indiv 8 27 27 BAI + + sr + AU
35. Naeem et al. (2014) Adults MDD CBT CAU Gsh 7 94 89 HADS-A −− sr − PK
36. Naeem et al. (2015) Adults MDD CBT CAU Indiv 7 69 68 HADS-A + + sr + PK
37. Pot et al. (2010) Older adults Dep symptoms Other (Life Review) Other Grp 12 83 88 HADS-A + + sr + NL
38. Pots et al. (2014) Adults Dep symptoms MBCT WL Grp 12 76 75 HADS-A + + sr + NL
39. Qiu et al. (2013) Adults w/breast cancer MDD CBT WL Grp 10 31 31 SAS + + sr + CN
40. Richards et al. (2015) Adults Dep symptoms CBT WL Gsh 7 96 92 GAD-7 + + sr + UK
41. Savard et al. (2006) Adults w/breast cancer Dep symptoms CBT WL Indiv 8 21 16 HADS-A + + sr − CA
42. Serfaty et al. (2009) Older adults Mood disorder CBT CAU Indiv 12 60 53 BAI + + sr − UK
43. Simson et al. (2008) Adults w/diabetes Dep symptoms SUP CAU Indiv 5 15 15 HADS-A −− sr + DE
44. Strong et al. (2008) Adults w/cancer MDD PST CAU Indiv 10 97 99 SCL-A + + sr + UK
45. Swartz et al. (2008) Mothers w/depression MDD IPT CAU Indiv 8 23 17 BAI −− sr + US
46. Talbot et al. (2011) Women w/hx sexual abuse MDD IPT CAU Indiv 16 31 22 PTSD-SSS −− sr + US
47. Tovote et al. (2014) Adults w/diabetes Dep symptoms MBCT WL Indiv 8 31 31 GAD-7 +− sr + NL
CBT
48. Vernmark et al. (2010) Adults MDD CBT std WL Gsh 7 29 29 BAI + + sr + SE
CBT tail 27
49. Vitriol et al. (2009) Women w/severe dep & hx child abuse Mood disorder DYN CAU Indiv 12 44 43 PTO −− + + CL
50. Warmerdam et al. (2008) Adults Dep symptoms CBT WL Gsh 8 88 87 HADS-A + + sr + NL
PST 88
51. Watkins et al. (2012) Adults Dep symptoms Other (CNT) CAU Gsh 3 33 37 GAD-7 + + sr + UK
52. Wierzbicki & Bartlett (1987) Adults Mood disorder CBT (ind) WL Indiv & Grp 6 9 20 A- state/ A-trait −− sr − US
CBT (grp)
CBT (grp)
aIn this column a positive or negative sign is given for four quality criteria, respectively: allocation sequence; concealment of allocation to conditions; blinding of assessors for anxiety outcomes; and intention-to-treat analyses.
N at post-treat, N for anxiety analysia; Guided self-help, online or book intervention with contact from therapist.
Clin, Clinical Sample; Comm, Community Sample, CBT, Cognitive Behavior Therapy; ACT, Acceptance and Commitment Therapy; MBCT, Mindfulness Based Cognitive Therapy; SUP, Supportive psychotherapy; IPT, Interpersonal Psychotherapy; BMS,
Body, Mind, Spirit Psychotherapy; DYN, Psychodynamic Psychotherapy; Indiv, Individual; Grp, Group; Gsh, guided self-help; CAU, Care-as-Usual; WL, Wait-list; BSL, Brief Symptom Inventory; BDI, Beck Depression Inventory; MADRS, Montgomery Åsberg
Depression Scale; CES-D, Center for Epidemiologic Studies Depression Scale ; HAM-D, Hamilton Rating Scale for Depression ; PHQ-9, Patient Health Questionnaire; EPDS, Edinburgh Post-natal Depression Scale; HADS, Hospital Anxiety Depression Scale;
GDS, Geriatric Depression Scale; IDS, Inventory of Depressive Symptomatology; SCL, Symptom Checklist; DHP, Duke Health Profile (depression); D30, Depression scale from the Minnesota Multiphasic Personality Inventory. BAI, Beck Anxiety Inventory;
STAI, State-trait Anxiety Inventory; ASQ, Anxiety Screening Questionnaire; GAD-7, Generalized Anxiety Disorder 7; PSWI, Penn State Worry Inventory; HAM-A, Hamilton Rating Scale for Anxiety; PTSD-SSS, Modified PTSD Symptom Scale Self-Report; PTO,
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Table 2. Results of meta-analysis of psychotherapy v. control conditions
N g 95% CI Z I2 95% CI p
Anxiety acute outcomes
All comparisons 62 0.52 0.44–0.60 12.58 55 40–66
One ES per study (only highest) 52 0.52 0.43–0.61 11.39 58 43–69
One ES per study (only lowest) 52 0.49 0.40–0.58 11.11 55 38–67
ES w/o outliers (9 comparisons) 53 0.49 0.42–0.55 15.09 14 0–40
BAI only 19 0.40 0.27–0.53 5.86 33 0–62
HADS-A only 15 0.58 0.43–0.73 7.50 69 48–82
Subgroup analyses
Type of psychotherapy
CBT 33 0.54 0.44–0.65 10.21 50 25–66 0.57
Other 29 0.49 0.36–0.62 7.53 61 41–74
Recruitment
Community 36 0.49 0.41–0.57 11.70 31 0–54 0.55
Clinical 14 0.62 0.36–0.87 4.73 73 54–84
Other 12 0.56 0.36–0.76 5.47 64 33–81
Formata
Individual 26 0.50 0.34–0.65 6.31 66 48–77 0.24
Group 17 0.46 0.33–0.59 7.04 30 0–61
Guided self-help 17 0.60 0.49–0.71 10.68 39 0–66
Depression diagnosis
MDD 19 0.60 0.45–0.76 7.71 56 26–74 0.40
Mood disorder 10 0.55 0.28–0.83 4.01 68 38–83
Depressive symptoms 33 0.48 0.39–0.58 9.89 44 16–63
Type of control group
WL 23 0.59 0.48–0.70 10.48 37 0–62 0.08
CAU 29 0.51 0.38–0.65 7.32 65 48–76
Other 10 0.38 0.23–0.53 5.05 26 0–64
Study quality
High 41 0.49 0.41–0.57 11.50 50 28–65 0.23
Low 21 0.62 0.42–0.83 5.97 62 40–76
Special population
Yes 33 0.42 0.33–0.51 8.94 32 0–55 0.01
No 29 0.61 0.49–0.73 10.08 57 35–72
Long-term effects post-baseline
Up to 7 month FU 11 0.25 0.13–0.37 4.15 0 0–60
Up to 14 month FU 10 0.27 0.17–0.38 5.05 0 0–62
Depression acute outcomes
All comparisons 62 0.63 0.54–0.71 14.45 59 46–69
One ES per study (only highest) 52 0.64 0.54–0.74 12.69 65 53–74
One ES per study (only lowest) 52 0.59 0.50–0.69 12.33 62 48–72
ES without outliers (eight comparisons) 54 0.61 0.55–0.67 19.44 13 0–38
aThe Wierzbicki & Bartlett (1987) study was removed from the analysis because both group and individual psychotherapy formats were utilized.
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scores in 62 comparisons (Table 2). The pooled effect size was g =
0.63 (95% CI 0.54–0.71; NNT = 2.82) and heterogeneity between
studies was moderate (I2 = 59%; CI 46–69). Eight outliers were
omitted from the meta-analysis and an effect size of g = 0.61
(95% CI 0.55–0.67; I2 = 13%, 95% CI 0–38) was observed.
Inspection of the funnel plot and Duval and Tweedie’s trim and
fill procedure indicated minor publication bias. Egger’s test of
the intercept was not significant ( p = 0.07). After adjustment
for missing studies the effect size was similar to the observed
effect size (g = 0.57; 95% CI 0.47–0.66).
In addition, eight studies examined multiple psychotherapy
interventions in one trial. Analyses utilizing only the highest and
then the lowest effect sizes per study were conducted (Table 2).
Subgroup and metaregression analysis
Subgroup analyses (see Table 2) showed no significant differ-
ences in effect sizes when examining differences in recruitment
method, depression inclusion criteria, psychotherapy format,
or study quality. The analysis did indicate a trend toward
studies with wait-list control groups displaying higher effect
sizes on anxiety than studies utilizing CAU or other control
conditions ( p = 0.08). In addition, studies on the general popu-
lation had a significantly higher effect size than those studies
with special populations, such as comorbid medical disorders
( p = 0.01).
Bivariate metaregression analyses examining associations
between anxiety effect sizes and continuous variables revealed
a significant association between depression and anxiety effect
sizes at post-treatment (Table 3, Fig. 3). Additional multivariate
metaregression analysis showed depression effect sizes remained
significantly associated with anxiety effect sizes at post-treatment
after controlling for study and clinical characteristics (Table 3).
Additionally, a number of treatment sessions did not predict
anxiety outcomes between psychotherapies and control condi-
tions (b = 0.00; p = 0.78).
Fig. 2. Forest plot of included studies.
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Long-term follow-up
Studies without wait-list control conditions, indicating partici-
pants never received the intervention, and that reported long-
term outcomes on anxiety measures were included in follow-up
analysis. The pooled effect size signifying the difference between
psychotherapy and control conditions in anxiety symptoms up
to 7 months post-baseline was g = 0.25 (95% CI 0.13–0.37), and
up to 14 months post-baseline was g = 0.27 (95% CI 0.17–0.38)
(Table 2).
Discussion
Our results indicate that, when comparing effect sizes, depres-
sion treatment (psychotherapy) is almost as effective at reducing
comorbid anxiety symptoms as it is at reducing depressive
symptoms. Moderate to large effect sizes were observed for anx-
iety symptoms (g = 0.52; NNT = 3.50) and for depression symp-
toms (g = 0.63; NNT = 2.82) with moderate heterogeneity and
little evidence that publication bias affected the results.
Long-term follow-up assessments revealed a small lasting effect
up to 1 year after baseline assessment (g = 0.27), although this
should be interpreted with some caution since studies used nat-
uralistic follow-up. For patients with commonly comorbid
depression and anxiety symptoms, choosing which treatment
to utilize may be challenging. However, these results suggest
that common evidence-based psychotherapies for depression
can ameliorate anxiety symptoms, and may be sufficient for
reducing anxiety symptoms without adjunctive treatments.
However, this meta-analysis was not able to discern if a specific
psychotherapy for depression is more effective at treating anx-
iety symptoms than others or if these psychotherapies are
equivalent to utilizing psychotherapies designed to treat anxiety
symptoms.
In comparison with previous meta-analyses, anxiety and
depression effect sizes found in this sample are comparable to
those reported in meta-analyses specifically examining the effects
of psychotherapy for anxiety or psychotherapy for depression.
Anxiety symptom effect sizes reported here are similar, although
slightly lower, than those previously reported in meta-analyses of
psychotherapies specifically targeting anxiety which have shown
large effect sizes (between 0.71 and 0.84) (Hunot et al. 2007;
Hofmann & Smits, 2008; Acarturk et al. 2009; Sanchez-Meca
et al. 2010; Cuijpers et al. 2014). This study found moderate effect
sizes of g = 0.52; however, the prior meta-analyses focused on
patients diagnosed with anxiety disorders and may include
patients with more severe anxiety symptoms. This indicates the
validity of the finding that psychotherapy targeting depression
also ameliorates anxiety symptoms.
Similarly, depression effect sizes reported here were equivalent
to previous meta-analyses which reported effect sizes of psycho-
therapy for depression v. control conditions between 0.56 and
0.82 (Gloaguen et al. 1998; Ekers et al. 2008; Sanchez-Meca
et al. 2010; Cuijpers et al. 2011, 2012, 2013a). While not all
depression trials comparing psychotherapies and controls pro-
vided anxiety measures and could be included in this
meta-analysis, the sample of trials included here are representative
in terms of effect sizes.
Table 3. Results of metaregression analysis
b 95% CI p value
Bivariate
Intercept 0.18 0.05–0.30 0.01
Depression ES 0.55 0.37–0.72 0.00
Multivariate
Intercept 0.36 0.04–0.67 0.03
Depression ES 0.52 0.33–0.72 0.00
Psychotherapy (CBT = 0) 0.02 −0.11–0.14 0.82
Recruitment − Clinical Ref
− Community −0.05 −0.26–0.15 0.61
− Other −0.07 −0.28–0.15 0.55
Format − Individual Ref
− Group −0.06 −0.25–0.13 0.55
− Gsh −0.01 −0.23–0.20 0.91
Dep type − MDD Ref
− Mood Dis 0.01 −0.21–0.23 0.92
− Symptoms 0.02 −0.15–0.20 0.78
Control − WL Ref
− CAU −0.01 −0.21–0.19 0.92
Other − Other −0.18 −0.36–0.01 0.04
Study quality (high = ref) 0.08 −0.09–0.25 0.33
Special pop (no = ref) −0.21 −0.38–−0.04 0.02
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Subgroup analysis revealed that studies without special popu-
lations exhibited significantly higher effect sizes than studies
that included special populations, such as those with a comorbid
medical diagnosis or post-partum depression. This may be due to
the varying populations included or high statistical heterogeneity
between the studies. Consistent with previous research, studies
with a wait-list control group displayed a trend towards higher
effect sizes than studies utilizing other control conditions
(Furukawa et al. 2014). No other significant subgroup analyses
were identified (including no difference in effect sizes based on
the type of psychotherapy, depression inclusion criteria, and con-
trol group utilized). It was not possible to examine the effective-
ness of the included psychotherapies separately due to the low
number of studies meeting criteria per psychotherapy included,
therefore providing insufficient statistical power to examine this
adequately. Examining whether specific types of psychotherapy
were equally effective for the treatment of anxiety symptoms
was not the main aim of the study. However, subgroup analysis
depicted similar outcomes between CBT and the other psy-
chotherapies included. Future research should examine which
specific psychotherapies are optimal for reducing anxiety
symptoms.
Separate analysis on anxiety measures found that the BAI pro-
duced lower effect sizes than the HADS-A. Although these were
both moderate effect sizes, the differences may be related to
study characteristics or to differences in the specific measures;
however, studies including both measures are needed to examine
this further. In addition, there is some heterogeneity among all
anxiety measurements included. Although only validated mea-
sures of general anxiety symptoms were utilized (with the excep-
tion of the two studies utilizing PTSD measures), the potential
effect of including specific measures could not be assessed in
this meta-analysis due to insufficient numbers of studies per anx-
iety measurement.
In addition multivariate metaregression, controlling for clinical
and study characteristics, demonstrated a significant association
between outcome depression and anxiety scores. This provides
support that anxiety and depression are highly connected, how-
ever the mechanisms of how depression psychotherapies treat
anxiety symptoms, whether certain components of the psy-
chotherapies are more effective than others, and whether depres-
sion and anxiety symptoms remit sequentially or simultaneously,
is still unclear and should be explored further using RCTs and
individual patient data meta-analyses.
Although this meta-analysis provides robust evidence that psy-
chotherapies for depression significantly reduce anxiety symp-
toms compared with controls, there are several additional
limitations to consider when interpreting these results. Only
half of the studies met all quality criteria, thus, a majority of
the trials included had a considerable risk of bias. The studies
scoring as lower quality had a higher effect size (although not sig-
nificantly) than those scoring as higher quality studies. Thus,
study results should be interpreted with some caution. Second,
although the meta-analysis includes considerable comparisons,
several of the subgroup analyses were conducted with few studies.
Thus, finding few significant differences in subgroup analyses
might be due to low statistical power and may not indicate that
effect sizes for these groups are equivalent. Further analysis of dif-
ferences in subgroups should be conducted as the evidence
accumulates.
Furthermore, because this meta-analysis was conducted on
secondary outcome measures, no anxiety symptom inclusion
Fig. 3. Metaregression of anxiety effect sizes on depression effect size.
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criteria were required. This implies that baseline anxiety scores for
some of the sample may not be in the clinical range. However,
because of the high levels of comorbidity between anxiety and
depressive symptoms, it is expected that a majority of patients
included in these studies had elevated symptoms of anxiety.
Nonetheless, these results may not pertain to patients with diag-
nosed comorbid mood and anxiety disorders and further analysis
including patients with elevated symptoms of both should be con-
ducted when enough evidence warrants analysis.
Despite these limitations, this meta-analysis provides evidence
for utilizing psychotherapies for depression to treat patients with
comorbid anxiety symptoms. When patients present with a main
complaint of depression, but exhibit general comorbid anxiety
symptoms, psychotherapies for depression can reduce symptoms
of anxiety without supplementary treatments. Although this
establishes that psychotherapies for depression reduce anxiety
symptoms on average (possibly through common factors), not
all participants with comorbid anxiety symptoms or disorders
will benefit from psychotherapy for depression and certain treat-
ments may be more efficacious for treating anxiety symptoms
than others (specific factors). Thus, future research should con-
tinue to examine which treatments, study, and individual charac-
teristics may affect treatment response for participants exhibiting
comorbid depression and anxiety.
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